TRAVEL and tourism businesses around the world are looking to capitalise on India’s double-digit annual growth in the outbound MICE and luxury travel segment, with the value of India’s business travel market expected to reach USD 93 billion by 2030, organisers of an industry event have said.
India has recently moved up two places to become the eighth largest business travel market in the world, and business travel spending in the country is projected to record a compound annual growth rate of 12 per cent through 2020, they said.
As India maintains its double-digit annual growth in the outbound meetings, incentives, conferences and exhibitions (MICE) and luxury travel segment, travel and tourism businesses around the world are looking to capitalise on the country’s growth potential.
The MICE market refers to a niche of group tourism dedicated for planning, booking, and facilitating conferences, seminars, and other events.
Forging business opportunities and partnerships with leading Indian corporates and luxury travel specialists will be discussed at the 6th annual MICE India and Luxury Travel (MILT) Congress, the premier B2B event that caters to both the business travel and luxury tourism sectors in India.
Organised by Dubai-based QnA International, the MILT Congress will be held this year in Mumbai from July 25-26 and in Delhi from July 31-August 01.
By 2030, the value of India’s business travel market is expected to reach USD 93 billion, a statement released here said.
Noting that Indian corporates remain largely unaffected by the global slowdown and continue to spend big on corporate travel, Hassan Madah, Director, Israel Ministry of Tourism – India and the Philippines, said.
India is among the largest source markets for MICE tourism in both Dubai and Abu Dhabi, and the travel and hospitality companies in both the Emirates are looking to further expand their reach in the Indian market by taking advantage of the unique networking opportunities provided by MILT Congress 2018 with its high-profile buyer lineup.
The United Nations World Tourism Organisation (UNWTO), meanwhile, has forecast that India will account for 50 million outbound tourists by 2020.
Business and luxury travel is expected to make up a significant share of the total volume of outbound travel, with one report indicating the country is on track to generating 6.5 million outbound luxury and MICE tourists annually by 2020.
Ackash Jain, Director, QnA International, said, “India has been maintaining an annual GDP growth rate of 6-8 per cent since 2013, and this strong economic momentum is rubbing off on the country’s outbound MICE and luxury travel sector, enabling these segments to post a double digit year- on-year growth”.
According to Jain, the rise of incentive travel, which has emerged as one of the fastest growing segments within India’s outbound business travel
market, is opening a new dimension of opportunities for travel and hospitality suppliers around the world.
The report titled “United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 – 2023” examines the market dynamics, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for NIPT test in United States. The research includes historic data from 2015 to 2017 and forecasts until 2023.
Long–term Growth Projection:
• United States is anticipated to be the most attractive market in the
Non-Invasive Prenatal Testing(NIPT) industry
• United States Non-Invasive Prenatal Testing(NIPT) is expected to
register a faster value growth during 2018 – 2023
• The Potential United States Non-Invasive Prenatal Testing(NIPT) Market
is set to cross USD 2.5 Billion by 2023
• MaterniT21 PLUS, Harmony, Verifi, Panorama are the popular test in the
United States Non-Invasive Prenatal Testing(NIPT) Market
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2023. The report also includes assessment of comparative test analysis by companies. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT test market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.
The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Illumina, Natera, Quest Diagnostics, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche)
Major and Promising NIPT test covered in the report are as follows:
MaterniT21 PLUS, VisibiliT, MaterniT21 GENOME, Harmony, Verifi, Panorama, Vistara and QNatal Advanced
The Latest Industry Data Included in this Report:
• Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• Average Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• High Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• Average Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• High Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• NIPT Test Market – Reimbursement & Regulation System
• NIPT Test Implementation in High–Income Countries
• Comparative Test Analysis – By Companies
• Major Deals in Non–Invasive Prenatal Testing Market
• Key Companies Analysis
• Key Market Drivers and Inhibitors of the United States NIPT Test Market
More Details @ http://www.globemarketreport.com/report-details.php?P_ID=84
The Global market for Neuromodulation is projected to reach more than US$5 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.
Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neuromodulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neuromodulation market.
North America is seen as the dominant player in the neuromodulation market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neuromodulation.
Spinal cord stimulation segment dominated the neuromodulation market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation. It is expected that deep brain stimulation will grasp nearly 20% market share by the year end of 2021.
Chronic Pain is identified as the largest application segment of the neuromodulation market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neuromodulation market.
Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the Neuromodulation market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report concludes with the profiles of major players in the global neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neuromodulation segment from 2010 to 2021.The report also entails major drivers and challenges of neuromodulation market.
Neuromodulation Market: Segmentation
Neuromodulation market is classified on the basis of technology, application, company and geography.
Based on Technology, Neuromodulation market can be segmented as follows:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Urinary Fecal Incontinence
Treatment Resistant Depression(TRD)
Obsessive Compulsive Disorder(OCD)
Based on Geography, Neuromodulation market can be segmented as follows:
Rest of the World (ROW)
Based on Company, Neuromodulation market can be segmented as follows:
St Jude Medical